Unsuccessful Fertility Drug Use Lowers Breast Cancer Risk

This article originally appeared here.
Unsuccessful Fertility Drug Use Lowers Breast Cancer Risk
Unsuccessful Fertility Drug Use Lowers Breast Cancer Risk

(HealthDay News) – Women with unsuccessful use of fertility drugs are at a significantly reduced risk of young-onset breast cancer, according to a study published online July 6 in the Journal of the National Cancer Institute.

To examine the association between fertility drug use and young-onset breast cancer, Chunyuan Fei, PhD, from the National Institute of Environmental Health Sciences in Research Triangle Park, NC, and colleagues conducted a sister-matched case-control study that included 1,422 cases who were <50 years at diagnosis with breast cancer, enrolled within four years of diagnosis, and 1,669 breast cancer-free control sisters.

The researchers found that 288 participants reported using ovulation-stimulating drugs (193 clomiphene citrate only; 29 follicle-stimulating hormone only; 66 both). Compared with nonusers, women who had used fertility drugs had a nonsignificantly decreased risk of breast cancer (odds ratio [OR], 0.82; 95% confidence interval [CI], 0.63–1.08). Compared with nonusers, women who had used fertility drugs but had not conceived a 10+ week pregnancy had a significantly decreased risk of breast cancer (OR, 0.62). Compared with unsuccessfully treated women, women who had conceived using fertility drugs had a significantly increased risk of breast cancer (OR, 1.82); their risk was similar to women who had not used fertility drugs (OR, 1.13; 95% CI, 0.78–1.64).

"In this sister-based case-control study, a history of unsuccessful use of ovulation-stimulating fertility drugs was associated with a statistically significantly reduced risk of young-onset breast cancer, but the occurrence of a stimulated 10+ week pregnancy appeared to offset the protective association," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial